Kavontae Smalls is a Communications Specialist at SurvivorNet. He focuses on various aspects of medicine and healthcare, including consumer health, mental health, oncology, and palliative care, while also exploring healthcare technology and alternative medicine. Kavontae's work has been featured in Atlanta Black Star, SurvivorNet, NewsBreak, and MSN.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Kavontae Smalls' articles predominantly cover stories related to health, cancer, and celebrity health. The majority of the content features expert commentary and profile features. To effectively reach out to Kavontae, consider providing access to experts in the field of cancer research or treatment who can offer valuable insights into new developments or provide unique perspectives on trending topics in cancer awareness and treatment.
Given Kavontae's focus on covering profiles of public figures dealing with health challenges, consider offering interviews with individuals who have overcome significant health obstacles or professionals who work closely with celebrities facing similar issues.
While there is no specified geographic focus for Kavontae's coverage, her interest seems centered around international news involving prominent personalities which could be relevant when considering potential sources.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Kavontae Smalls
After an elevated prostate-specific antigen (PSA) test, which helped screen for prostate cancer, left him reeling, longtime public health educator Dr. Maurice Franklin turned to SurvivorNet’s AI-powered My Health Questions tool for clarity and support between appointments.
By: Kavontae Smalls
Women with cancer tend to live longer than men, according to a large study published in the Journal of the National Cancer Institute, where more than 20,000 patients were examined. The study adds that although women cancer patients tend to see a lower risk of death (21%) compared to men, they also face a 12% higher risk of severe treatment side effects.
By: Kavontae Smalls
Cancer is not an outside invader but a biological process, explains Dr. Alexandra Drakaki, medical director of the Genitourinary Oncology Program at UCLA. She adds that understanding that reality can help patients regain clarity and control after a diagnosis.
By: Kavontae Smalls
Olympic distance runner Ciara Mageean’s upcoming memoir shifted from a medal‑chasing sports story to an “honest and raw” account shaped by her unexpected and undisclosed cancer diagnosis.
By: Kavontae Smalls
0 seconds of 3 minutes, 23 seconds Volume 100% Oncologist Brings His Lived Experience to Cancer Care
By: Kavontae Smalls
Popular 1970s actress Pam Grier, 76, survived a harrowing battle with advanced cervical cancer decades after a relationship with Richard Pryor, whose heavy cocaine use she believes may have indirectly exposed her to the drug.
By: Kavontae Smalls
“Love Island” star Lexy Thornberry, 25, has completed radiation treatment for head and neck cancer and celebrated by ringing the bell and spending long‑missed time with her family.
By: Kavontae Smalls
New data from the SISTER trial, presented at the Society of Gynecologic Oncology (SGO) Annual Meeting, show that one-to-one peer support significantly improves treatment completion rates for women with high-grade endometrial cancer.
Early data show the cancer drug mocertatug rezetecan (Mo‑Rez) delivering response rates above 60% in patients with ovarian and endometrial cancers that have returned after earlier treatment (recurrence).
By: Kavontae Smalls
Jamie‑Lynn Sigler says the “emotional and physical toll” of hiding her multiple sclerosis diagnosis pushed her to finally speak out, adding she carried “labels… like shame” despite having “no reason to feel shame about living with MS,” Sigler explained to SurvivorNet.
